Flecainide or Propafenone vs Vernakalant for Conversion of Recent-Onset Atrial Fibrillation
Gespeichert in:
| Veröffentlicht in: | Canadian journal of cardiology 2013-10, Vol.29 (10), p.1330.e13-1330.e13 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1330.e13 |
|---|---|
| container_issue | 10 |
| container_start_page | 1330.e13 |
| container_title | Canadian journal of cardiology |
| container_volume | 29 |
| creator | Conde, Diego, MD Costabel, Juan Pablo, MD Aragon, Martin, MD Caro, Milagros, MD Ferro, Alejandra, MD Klein, Andres, MD Trivi, Marcelo, MD Giniger, Alberto, MD |
| description | |
| doi_str_mv | 10.1016/j.cjca.2013.01.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1438569791</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0828282X13000056</els_id><sourcerecordid>1438569791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-4139d9e4bca830c0ea177848423d030ee57777f54140449e94ece552ef9da58b3</originalsourceid><addsrcrecordid>eNp9UU2LFDEQDaK4465_wIPk6KXbyld_gAjLsKPCwoq6IngImXQ1pDeTjEnPwP5708y6hz1YlzrUe6-q3iPkDYOaAWveT7WdrKk5MFEDqwH4M7JiPWuqFlr1nKyg413FO_7rjLzKeQKQrG2bl-SMC9koIdsV-b3xaI0LbkAaE_2a4t6MGGJAesz0J6Zg7ow3YaZjGa9jOGLKLgYaR_oNLYa5ugkZZ3o5J2c83bhtct6buWAuyIvR-IyvH_o5ud1c_Vh_rq5vPn1ZX15XVjR8riQT_dCj3FrTCbCAplzZyU5yMYAARNWWGpVkEqTssZdlr1Icx34wqtuKc_LupLtP8c8B86x3LlssVwSMh6yZFJ1q-rZnBcpPUJtizglHvU9uZ9K9ZqAXU_WkF1P1YqoGpouphfT2Qf-w3eHwSPnnYgF8OAGwfHl0mHS2DoPFwSW0sx6i-7_-xyd060si1vg7vMc8xUNJwZc_dOYa9Pcl1iVVJqCUasRfHJec0Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1438569791</pqid></control><display><type>article</type><title>Flecainide or Propafenone vs Vernakalant for Conversion of Recent-Onset Atrial Fibrillation</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Conde, Diego, MD ; Costabel, Juan Pablo, MD ; Aragon, Martin, MD ; Caro, Milagros, MD ; Ferro, Alejandra, MD ; Klein, Andres, MD ; Trivi, Marcelo, MD ; Giniger, Alberto, MD</creator><creatorcontrib>Conde, Diego, MD ; Costabel, Juan Pablo, MD ; Aragon, Martin, MD ; Caro, Milagros, MD ; Ferro, Alejandra, MD ; Klein, Andres, MD ; Trivi, Marcelo, MD ; Giniger, Alberto, MD</creatorcontrib><identifier>ISSN: 0828-282X</identifier><identifier>EISSN: 1916-7075</identifier><identifier>DOI: 10.1016/j.cjca.2013.01.002</identifier><identifier>PMID: 23465347</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Anisoles - therapeutic use ; Anti-Arrhythmia Agents - therapeutic use ; Atrial Fibrillation - drug therapy ; Atrial Fibrillation - physiopathology ; Cardiovascular ; Electrocardiography ; Europe ; Flecainide - therapeutic use ; Humans ; Practice Guidelines as Topic ; Propafenone - therapeutic use ; Pyrrolidines - therapeutic use</subject><ispartof>Canadian journal of cardiology, 2013-10, Vol.29 (10), p.1330.e13-1330.e13</ispartof><rights>Canadian Cardiovascular Society</rights><rights>2013 Canadian Cardiovascular Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c362t-4139d9e4bca830c0ea177848423d030ee57777f54140449e94ece552ef9da58b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cjca.2013.01.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23465347$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Conde, Diego, MD</creatorcontrib><creatorcontrib>Costabel, Juan Pablo, MD</creatorcontrib><creatorcontrib>Aragon, Martin, MD</creatorcontrib><creatorcontrib>Caro, Milagros, MD</creatorcontrib><creatorcontrib>Ferro, Alejandra, MD</creatorcontrib><creatorcontrib>Klein, Andres, MD</creatorcontrib><creatorcontrib>Trivi, Marcelo, MD</creatorcontrib><creatorcontrib>Giniger, Alberto, MD</creatorcontrib><title>Flecainide or Propafenone vs Vernakalant for Conversion of Recent-Onset Atrial Fibrillation</title><title>Canadian journal of cardiology</title><addtitle>Can J Cardiol</addtitle><subject>Anisoles - therapeutic use</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Atrial Fibrillation - drug therapy</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Cardiovascular</subject><subject>Electrocardiography</subject><subject>Europe</subject><subject>Flecainide - therapeutic use</subject><subject>Humans</subject><subject>Practice Guidelines as Topic</subject><subject>Propafenone - therapeutic use</subject><subject>Pyrrolidines - therapeutic use</subject><issn>0828-282X</issn><issn>1916-7075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU2LFDEQDaK4465_wIPk6KXbyld_gAjLsKPCwoq6IngImXQ1pDeTjEnPwP5708y6hz1YlzrUe6-q3iPkDYOaAWveT7WdrKk5MFEDqwH4M7JiPWuqFlr1nKyg413FO_7rjLzKeQKQrG2bl-SMC9koIdsV-b3xaI0LbkAaE_2a4t6MGGJAesz0J6Zg7ow3YaZjGa9jOGLKLgYaR_oNLYa5ugkZZ3o5J2c83bhtct6buWAuyIvR-IyvH_o5ud1c_Vh_rq5vPn1ZX15XVjR8riQT_dCj3FrTCbCAplzZyU5yMYAARNWWGpVkEqTssZdlr1Icx34wqtuKc_LupLtP8c8B86x3LlssVwSMh6yZFJ1q-rZnBcpPUJtizglHvU9uZ9K9ZqAXU_WkF1P1YqoGpouphfT2Qf-w3eHwSPnnYgF8OAGwfHl0mHS2DoPFwSW0sx6i-7_-xyd060si1vg7vMc8xUNJwZc_dOYa9Pcl1iVVJqCUasRfHJec0Q</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Conde, Diego, MD</creator><creator>Costabel, Juan Pablo, MD</creator><creator>Aragon, Martin, MD</creator><creator>Caro, Milagros, MD</creator><creator>Ferro, Alejandra, MD</creator><creator>Klein, Andres, MD</creator><creator>Trivi, Marcelo, MD</creator><creator>Giniger, Alberto, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131001</creationdate><title>Flecainide or Propafenone vs Vernakalant for Conversion of Recent-Onset Atrial Fibrillation</title><author>Conde, Diego, MD ; Costabel, Juan Pablo, MD ; Aragon, Martin, MD ; Caro, Milagros, MD ; Ferro, Alejandra, MD ; Klein, Andres, MD ; Trivi, Marcelo, MD ; Giniger, Alberto, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-4139d9e4bca830c0ea177848423d030ee57777f54140449e94ece552ef9da58b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Anisoles - therapeutic use</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Atrial Fibrillation - drug therapy</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Cardiovascular</topic><topic>Electrocardiography</topic><topic>Europe</topic><topic>Flecainide - therapeutic use</topic><topic>Humans</topic><topic>Practice Guidelines as Topic</topic><topic>Propafenone - therapeutic use</topic><topic>Pyrrolidines - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Conde, Diego, MD</creatorcontrib><creatorcontrib>Costabel, Juan Pablo, MD</creatorcontrib><creatorcontrib>Aragon, Martin, MD</creatorcontrib><creatorcontrib>Caro, Milagros, MD</creatorcontrib><creatorcontrib>Ferro, Alejandra, MD</creatorcontrib><creatorcontrib>Klein, Andres, MD</creatorcontrib><creatorcontrib>Trivi, Marcelo, MD</creatorcontrib><creatorcontrib>Giniger, Alberto, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Conde, Diego, MD</au><au>Costabel, Juan Pablo, MD</au><au>Aragon, Martin, MD</au><au>Caro, Milagros, MD</au><au>Ferro, Alejandra, MD</au><au>Klein, Andres, MD</au><au>Trivi, Marcelo, MD</au><au>Giniger, Alberto, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Flecainide or Propafenone vs Vernakalant for Conversion of Recent-Onset Atrial Fibrillation</atitle><jtitle>Canadian journal of cardiology</jtitle><addtitle>Can J Cardiol</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>29</volume><issue>10</issue><spage>1330.e13</spage><epage>1330.e13</epage><pages>1330.e13-1330.e13</pages><issn>0828-282X</issn><eissn>1916-7075</eissn><cop>England</cop><pub>Elsevier Inc</pub><pmid>23465347</pmid><doi>10.1016/j.cjca.2013.01.002</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0828-282X |
| ispartof | Canadian journal of cardiology, 2013-10, Vol.29 (10), p.1330.e13-1330.e13 |
| issn | 0828-282X 1916-7075 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1438569791 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Anisoles - therapeutic use Anti-Arrhythmia Agents - therapeutic use Atrial Fibrillation - drug therapy Atrial Fibrillation - physiopathology Cardiovascular Electrocardiography Europe Flecainide - therapeutic use Humans Practice Guidelines as Topic Propafenone - therapeutic use Pyrrolidines - therapeutic use |
| title | Flecainide or Propafenone vs Vernakalant for Conversion of Recent-Onset Atrial Fibrillation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T13%3A50%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Flecainide%20or%20Propafenone%20vs%20Vernakalant%20for%20Conversion%20of%20Recent-Onset%20Atrial%20Fibrillation&rft.jtitle=Canadian%20journal%20of%20cardiology&rft.au=Conde,%20Diego,%20MD&rft.date=2013-10-01&rft.volume=29&rft.issue=10&rft.spage=1330.e13&rft.epage=1330.e13&rft.pages=1330.e13-1330.e13&rft.issn=0828-282X&rft.eissn=1916-7075&rft_id=info:doi/10.1016/j.cjca.2013.01.002&rft_dat=%3Cproquest_cross%3E1438569791%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1438569791&rft_id=info:pmid/23465347&rft_els_id=S0828282X13000056&rfr_iscdi=true |